Outside the United States, the therapeutic community (TC) model is widely embraced, with currently 65 countries offering treatments and over 3,000 TC models incorporated into community settings across ...
When choosing rodent models for drug discovery investigations, it’s important to keep in mind that the ultimate goal is developing novel treatments for human diseases. Thus, choosing human disease ...
German pharmaceutical company Boehringer Ingelheim and tech giant IBM are teaming up to harness the power of genAI and foundation models to further biologic drug discovery. The partnership leverages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results